Skip to main content

Month: January 2025

UniFirst Confirms Rejection of Unsolicited, Non-Binding and Highly Conditional Acquisition Proposal from Cintas Corporation

WILMINGTON, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) — UniFirst Corporation (NYSE: UNF) (“UniFirst” or the “Company”) today confirmed that in November and December 2024, its Board of Directors received and unanimously rejected an unsolicited, non-binding and highly conditional proposal from Cintas Corporation to acquire all outstanding common and Class B shares of UniFirst for $275.00 per share. Consistent with its fiduciary duties and in consultation with its independent advisors, the Board conducted a careful review of the unsolicited proposal and determined that it is not in the best interests of UniFirst, its shareholders and other stakeholders. In making its determination, the Board considered the offer price, execution and business risks, feedback from some of the Company’s largest shareholders by voting power, and the Company’s...

Continue reading

FLUENT Unveils Bag-O: A New Value Brand for Florida Medical Marijuana Patients, Launching January 7

All Flower Products Launching Exclusively in 14-Gram Bags TAMPA, Fla., Jan. 07, 2025 (GLOBE NEWSWIRE) — Cansortium Inc. (CSE: TIUM.U) (OTCQB: CNTMF) (“Cansortium” or the “Company”), a vertically integrated, multi-state cannabis company operating under the FLUENT™ brand, today announces the launch of Bag-O, a new value-focused line of premium cannabis flower, available to Florida medical marijuana patients starting January 7. With an emphasis on quality and affordability, Bag-O offers patients access to cannabis at competitive prices, expanding FLUENT’s product offerings and reinforcing its commitment to accessibility. “Bag-O was developed in direct response to patient feedback, addressing the growing demand for larger quantities of high-quality cannabis at an affordable price point,” said Robert Beasley, CEO of FLUENT. “Thanks...

Continue reading

Freddie Mac Appoints James Whitlinger Chief Financial Officer

Ten-year company veteran named EVP & CFO effective immediately MCLEAN, Va., Jan. 07, 2025 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today announced the appointment of James Whitlinger as executive vice president and chief financial officer (CFO), effective January 1, 2025. Whitlinger previously served as the company’s senior vice president and Single-Family CFO since 2014. He has served as interim CFO since June of 2024, following the departure of Christian Lown, who served as CFO from June of 2020 to June 2024. “It’s with great pleasure that we announce Jim Whitlinger as the company’s new chief financial officer,” said Diana Reid, Chief Executive Officer of Freddie Mac. “Jim is a proven leader with more than 30 years of financial management and accounting experience. As a 10-year veteran of Freddie Mac, he is well positioned...

Continue reading

West Red Lake Gold Announces Positive Pre-Feasibility Study Results for Madsen Gold Mine with $315M After-Tax NPV and $70M Average Annual Free Cash Flow

VANCOUVER, British Columbia, Jan. 07, 2025 (GLOBE NEWSWIRE) — West Red Lake Gold Mines Ltd. (“West Red Lake Gold” or the “Company”) (TSXV: WRLG) (OTCQB: WRLGF) is pleased to announce the results of the pre-feasibility study (“PFS”) prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI 43-101”) for the imminent restart of its 100% owned Madsen Mine project in the Red Lake Gold District of northwestern Ontario, Canada. West Red Lake Gold will hold a conference call on January 8th at 11:00am ET, followed by a question-and-answer period. To access the call, please register here: https://www.amvestcapital.com/webinar-directory/westredlakegoldmines010825. The webinar will be archived for viewing at www.westredlakegold.com All dollar amounts in this news release are in Canadian dollars...

Continue reading

Devon Energy Schedules Fourth-Quarter and Full-Year 2024 Earnings Release and Conference Call

OKLAHOMA CITY, Jan. 07, 2025 (GLOBE NEWSWIRE) — Devon Energy Corp. (NYSE: DVN) today announced it will report fourth-quarter and full-year 2024 results on Tuesday, Feb. 18, after the close of U.S. financial markets. The earnings release and presentation for the fourth-quarter 2024 results will be available on the company’s website at www.devonenergy.com. On Wednesday, Feb. 19, the company will hold a conference call at 10 a.m. CST (11 a.m. EST), which will consist primarily of answers to questions from analysts and investors. A webcast link to the conference call will be provided on Devon’s website at www.devonenergy.com. A replay will be available on the website following the call. ABOUT DEVON ENERGY Devon Energy is a leading oil and gas producer in the U.S. with a premier multi-basin portfolio headlined by a world-class acreage...

Continue reading

GCC Announces Q4 2024 Conference Call Details

CHIHUAHUA, Mexico, Jan. 07, 2025 (GLOBE NEWSWIRE) — GCC, S.A.B. de C.V. (BMV: GCC*), a leading producer of cement and concrete in the United States and Mexico, will host a conference call to review its fourth quarter 2024 earnings results on Wednesday, January 29 at 10:00 a.m. (ET). Earnings results for the quarter ended December 31, 2024, will be released on Tuesday, January 28, after market close. The call will be hosted by Enrique Escalante, CEO, and Maik Strecker, CFO, and can be accessed by dialing +1 (877) 407 0789 or +1 (201) 689 8562 for international calls. The conference ID is 13750646. The presentation and listen-only webcast will be available via the following link. A replay of the webcast will be available the same day at 2:00 p.m. (ET) until February 5 at 11:59 p.m. (ET). The replay can be accessed through this link...

Continue reading

Rethinking Diabetes Care: PatentVest Pulse Unveils Key Insights on the Expanding CGM Market and the Innovations Driving Change

Addison, TX, Jan. 07, 2025 (GLOBE NEWSWIRE) — PatentVest, a leader in intellectual property (IP) intelligence and strategy, has released its latest report, “Continuous Glucose Monitoring (CGM): An Evolving Innovation Landscape.” This in-depth analysis explores the rapidly growing CGM market, offering valuable insights into the trends, key players, and opportunities that are shaping the future of diabetes care. Diabetes is one of the most pressing global health challenges, affecting an estimated 537 million adults worldwide in 2021—a number projected to rise to 783 million by 2045. As the complexity of diabetes management grows, the need for continuous, real-time glucose monitoring has never been more critical. Continuous Glucose Monitors (CGMs) address these challenges by providing patients with timely insights into their glucose...

Continue reading

Kaldvik AS: Resignation of board member

Reykjavík, 7 January 2025:  Aðalsteinn Ingólfsson has today notified the board of directors that he resigns as board member of Kaldvik AS. Mr. Ingólfsson has been a member of the board of directors since September 2022. His resignation has been accepted and is effective immediately. On behalf of the company, the board of directors extends its gratitude to Aðalsteinn for his service and contributions over the past years. For further information, please contact:Contacts: Róbert Róbertsson, CFO of Kaldvik AS: +354 843 0086 (mobile) About Kaldvik ASKaldvik AS is one of the leading salmon farmers in Iceland. Kaldvik AS has a well-developed and fully integrated value-chain controlling all steps from hatchery to sales, enabling the group to provide its customer with a sustainable premium product. Kaldvik AS is headquartered in Iceland. This information...

Continue reading

Dassault Aviation: Total number of shares and voting rights – 31 12 24

DASSAULT AVIATION French corporation (société anonyme) with a share capital of 62,876,448.80 euros Headquarters: 9, Rond-Point des Champs-Élysées – Marcel Dassault 75008 PARIS 712 042 456 RCS Paris Information concerning the total number of voting rights and shares as per article L. 233-8 II of the French Commercial Code (Code de commerce) and article 223-16 of the General Regulations (Règlement Général) of the French Market Authority (Autorité des Marchés Financiers)DateTotal number of sharesTotal number of voting rights12/31/2024 78,595,561Theoretical voting rights: 130,723,214 Exercisable voting rights: 130,326,152AttachmentTotal number of shares and voting rights – 31 12 24

Continue reading

AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering

IRVINE, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) — AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar pathway, today announced the closing of its previously announced firm commitment underwritten public offering. Gross proceeds to the Company were approximately $20.0 million, before deducting underwriting fees and other estimated offering expenses payable by the Company. The offering closed on January 7, 2025. The offering consisted of 40,000,000 Common Units, each consisting of (i) one (1) share of Common Stock, (ii) one (1) Series A Registered Common Warrant to purchase one (1) share of Common Stock per warrant at an exercise price of $0.625 (the “Series A Warrants”) and (iii) one (1) Series B Registered Common Warrant...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.